VBIV: VBI Vaccines, Inc. Price Target Chart

VBI Vaccines Inc. (VBIV) specializes in developing treatments for cancer and infections, generating revenue through the sale of its hepatitis B vaccine and grants. This daily price chart reflects the asset's dynamics, where the indicator stands at 4.98. Production is automated using bioreactors, which eliminates manual labor. Operations are strictly regulated by the FDA, while the environmental focus is limited solely to the proper disposal of biohazardous waste.

This indicator represents the weighted average of target prices from industry experts, filtering out market noise to identify the long-term vector of the asset's fundamental value. By analyzing the consensus target price of the stock, an investor assesses the growth potential of VBI Vaccines Inc. (VBIV), which depends directly on the efficiency of production capacity diversification and the resilience of supply chains when delivering vaccines amid global quarantine restrictions.